<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04681937</url>
  </required_header>
  <id_info>
    <org_study_id>4350611</org_study_id>
    <nct_id>NCT04681937</nct_id>
  </id_info>
  <brief_title>Comparison of Hyaluronic Acid, PRP and Steroid Injections in Partial Rotator Cuff Tears: A Prospective Randomized Study</brief_title>
  <official_title>Clinical and Radiological Comparison of the Efficacy of Hyaluronic Acid, PRP and Steroid Injections in Partial Rotator Cuff Tears: A Prospective Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bezmialem Vakif University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bezmialem Vakif University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are many conservative treatment options available for partial rotator cuff tears.&#xD;
      However, the superiority of a certain type of injection could not be demonstrated with the&#xD;
      available data. Our aim is to compare the effectiveness of steroid, hyaluronic acid, prp and&#xD;
      placebo (normal saline) injections in partial rotator cuff tears by applying the same&#xD;
      physical therapy protocol after injection.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2021</start_date>
  <completion_date type="Anticipated">September 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>American Shoulder and Elbow Surgeons Shoulder Score (ASES)</measure>
    <time_frame>12 months after injection</time_frame>
    <description>minimum score:0, maximum score:100, 100 is better function.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Constant-Murley Shoulder Outcome Score (CMS)</measure>
    <time_frame>12 months after injection</time_frame>
    <description>minimum score:0, maximum score:100, 100 is better function.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analogue scale (VAS)</measure>
    <time_frame>12 months after injection</time_frame>
    <description>minimum score:0, maximum score:10, 0 is better function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective Shoulder Value (SSV)</measure>
    <time_frame>12 months after injection</time_frame>
    <description>minimum score:0, maximum score:100, 100 is better function.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of Motion (ROM)</measure>
    <time_frame>12 months after injection</time_frame>
    <description>Active Shoulder Range of Motion Measurements</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Partial Tear of Rotator Cuff</condition>
  <condition>Rotator Cuff Tears</condition>
  <arm_group>
    <arm_group_label>Hyaluronic Acid + Physical Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4 ml hyaluronic acid (subacromial)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Platelet-Rich-Plasma (PRP) + Physical Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4 ml platelet-rich-plasma (subacromial)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Steroid + Physical Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>methylprednisolone acetate (1ml methylprednisolone acetate + 3 ml serum saline) (subacromial)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo (serum saline) + Physical Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4 ml serum saline (subacromial)</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Subacromial Injection (hyaluronic acid) + Physical Therapy.</intervention_name>
    <description>arm1: sodium hyaluronate (4ml) arm2: platelet-rich-plasma (4ml) arm3: methylprednisolone acetate (1ml methylprednisolone acetate + 3 ml serum saline) arm4: serum saline (4ml) The same physical therapy procedure will be applied to all arms after injection.</description>
    <arm_group_label>Hyaluronic Acid + Physical Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Subacromial Injection (Platelet-Rich-Plasma) + Physical Therapy.</intervention_name>
    <description>arm1: sodium hyaluronate (4ml) arm2: platelet-rich-plasma (4ml) arm3: methylprednisolone acetate (1ml methylprednisolone acetate + 3 ml serum saline) arm4: serum saline (4ml) The same physical therapy procedure will be applied to all arms after injection.</description>
    <arm_group_label>Platelet-Rich-Plasma (PRP) + Physical Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Subacromial Injection (methylprednisolone acetate) + Physical Therapy.</intervention_name>
    <description>arm1: sodium hyaluronate (4ml) arm2: platelet-rich-plasma (4ml) arm3: methylprednisolone acetate (1ml methylprednisolone acetate + 3 ml serum saline) arm4: serum saline (4ml) The same physical therapy procedure will be applied to all arms after injection.</description>
    <arm_group_label>Steroid + Physical Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Subacromial Injection (Serum Saline) + Physical Therapy.</intervention_name>
    <description>arm1: sodium hyaluronate (4ml) arm2: platelet-rich-plasma (4ml) arm3: methylprednisolone acetate (1ml methylprednisolone acetate + 3 ml serum saline) arm4: serum saline (4ml) The same physical therapy procedure will be applied to all arms after injection.</description>
    <arm_group_label>Placebo (serum saline) + Physical Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  persistent continous pain at least 3 months&#xD;
&#xD;
          -  partial thickness rotator cuff tear on MRI&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  inflammatory disease&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  known malignancy&#xD;
&#xD;
          -  bleeding disorder ( or &lt;10 g/dl Hb level, &lt;150.000 ul platelet)&#xD;
&#xD;
          -  previous shoulder injection&#xD;
&#xD;
          -  history of shoulder surgery&#xD;
&#xD;
          -  full-thickness tear&#xD;
&#xD;
          -  other shoulder problem (osteoarthritis, bony lesions, etc)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Bezmialem Vakif University</name>
      <address>
        <city>Istanbul</city>
        <zip>34093</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bezmialem Vakif University</name>
      <address>
        <city>Istanbul</city>
        <zip>34093</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <contact>
      <last_name>Vahdet Ucan, MD</last_name>
      <phone>+905546586750</phone>
      <email>vahdetucan@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>December 13, 2020</study_first_submitted>
  <study_first_submitted_qc>December 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 23, 2020</study_first_posted>
  <last_update_submitted>May 28, 2021</last_update_submitted>
  <last_update_submitted_qc>May 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bezmialem Vakif University</investigator_affiliation>
    <investigator_full_name>Muzaffer Ağır</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>partial rotator cuff tear</keyword>
  <keyword>subacromial injection</keyword>
  <keyword>plateled-rich-plasma</keyword>
  <keyword>physical therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rotator Cuff Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Acetate</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

